Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program
Mechelen, Belgium; November 16, 2026; 7.30 AM CET regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today announced the initiation of a new share repurchase program of up to €50 million, following completion of its initial €50 million program announced on June 9, 2026. Under the initial program, completed on October 16, 2026, Lakefront repurchased approximately 1.99 million ordinary shares for a total consideration of €50 million. The repurchased shares are held as treasury shares. The new program will be carried out by Morgan Stanley & Co International PLC, acting as an independent financial intermediary under a discretionary mandate and making its trading de